Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03RGP
|
||||
| Former ID |
DNC011406
|
||||
| Drug Name |
(R,S)-AMPA
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529714] | ||
| Structure |
|
Download |
|||
| Formula |
C7H10N2O4
|
||||
| Canonical SMILES |
CC1=C(C(=O)NO1)CC(C(=O)O)N
|
||||
| InChI |
1S/C7H10N2O4/c1-3-4(6(10)9-13-3)2-5(8)7(11)12/h5H,2,8H2,1H3,(H,9,10)(H,11,12)
|
||||
| InChIKey |
UUDAMDVQRQNNHZ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Glutamate receptor AMPA subtype | Target Info | Inhibitor | [529714] | |
| Glutamate receptor, ionotropic kainate 1 | Target Info | Inhibitor | [529714] | ||
| Glutamate receptor 1 | Target Info | Inhibitor | [529714] | ||
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Glutamatergic synapsehsa04024:cAMP signaling pathway | |||||
| Circadian entrainment | |||||
| Long-term potentiation | |||||
| Retrograde endocannabinoid signaling | |||||
| Glutamatergic synapse | |||||
| Dopaminergic synapse | |||||
| Long-term depression | |||||
| Amyotrophic lateral sclerosis (ALS) | |||||
| Amphetamine addiction | |||||
| Nicotine addiction | |||||
| Pathway Interaction Database | EPHB forward signaling | ||||
| References | |||||